Glazer Capital LLC’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Glazer Capital LLC’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-324,517	Closed	-$32.5M	–	99
2015 Q1	$32.5M	Buy	+324,517	New	+$21.6M	4.9%	8

Glazer Capital LLC's ASPX Position: Q2 2015 in Review

Glazer Capital LLC sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 324,517 shares — an estimated $32.5M sold.

Glazer Capital LLC first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $32.5M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

Glazer Capital LLC reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Glazer Capital LLC sold 324,517 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $32.5M.
Glazer Capital LLC first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
Glazer Capital LLC's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $32.5M in Q1 2015.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Glazer Capital LLC's 13F filing for Q2 2015, filed 14 Aug 2015.